Patent Assignment
Reel/Frame 038674/0912
Change of Name
Recorded: 2016-05-11
Pages: 3
Assignor
BERG PHARMA LLC
Executed: 2013-04-05
Assignee
BERG LLC
1845 ELM HILL PIKE, NASHVILLE, TENNESSEE, 37210
Covered Properties
(3)
Methods for Treatment of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Methods for Treatment of Metabolic Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application:
12/778,054 →
Publication:
US 2011/0020312
Assay System for the Assessment of Oncogenicity, Tumor Progression, and Treatment Efficacy
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 19, 2012
From: BERG BIOSYSTEMS, LLC
To: BERG PHARMA LLC
Reel/Frame 028590/0308 →
Assignment of Assignor's Interest
Jun 2, 2023
From: BERG LLC
To: BPGBIO, INC.
Reel/Frame 063842/0405 →
Security Interest
Apr 21, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 070903/0693 →
Corrective Assignment to Correct the Patent Number 8147825 Was Added Previously Recorded at Reel: 70903 Frame: 693. Assignor(S) Hereby Confirms the Security Agreement.
Apr 30, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 071285/0001 →
Security Interest
Aug 29, 2025
From: BPGBIO INC.
To: BERG SURVIVOR’S TRUST; BERG, KARA ANN; THLIVERIS, ANDREW T.
Reel/Frame 072805/0303 →